The prevalence of child and adolescent obesity has plateaued at high levels in most high-
income countries and is increasing in many low-income and middle-income countries …

To date, non-alcoholic fatty liver disease (NAFLD) is the most frequent liver disease,
affecting up to 70% of patients with diabetes. Currently, there are no specific drugs available …

Large language models such as ChatGPT can produce increasingly realistic text, with
unknown information on the accuracy and integrity of using these models in scientific writing …

Background Large language models such as ChatGPT can produce increasingly realistic
text, with unknown information on the accuracy and integrity of using these models in …

Obesity is a chronic, progressive and relapsing disease with a rising global prevalence
associated with increased morbidity and mortality and reduced quality of life. Treatment of …

The discovery and development of so-called gut hormone co-agonists as a new class of
drugs for the treatment of diabetes and obesity is considered a transformative breakthrough …

Adolescent polycystic ovary syndrome (PCOS) is a highly prevalent, reversible, endocrine-
metabolic mode essentially driven by ectopic fat, which, in turn, often results from a …

Obesity is a chronic disease with high prevalence and associated comorbidities, making it a
growing global concern. These comorbidities include type 2 diabetes, hypertension …

Traditional approaches to prevention of the complications of type 2 diabetes (T2D) and
obesity have focused on reduction of blood glucose and body weight. The development of …

Key Clinical Points Obesity in Adolescents Adolescent patients with obesity benefit from
evaluation and follow-up according to a long-term care model with attention to and …